B · Normal
[Hong Kong Stock IPO: Nanjing Noling Biotechnology Co., Ltd. submitted to the Hong Kong Stock Exchange] On August 28, Livermore Securities showed that Nanjing Noling Biotechnology Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange, and the exclusive sponsor was CCB International.
港股动态 🕐 2026-08-28 22:52
#Hong Kong stock trends #Hong Kong stock IPO news
← Telegraph

Related telegraphs

[Hong Kong Stock IPO: Exegenesis Bio Company Submits to Hong Kong Stock Exchange 08-28 22:46 [Hong Kong Stock IPO: Mediterranean Resort Group Submits Listing to Hong Kong St 08-28 22:42 [Hong Kong Stock IPO: Frontera Therapeutics submits to Hong Kong Stock Exchange] 08-28 22:40 [Hong Kong Stock IPO: Betta Pharmaceuticals Co., Ltd. submitted to the Hong Kong 08-28 22:39 [Hong Kong Stock IPO: Hangzhou Tangji Medical Technology Co., Ltd.-B submitted t 08-28 22:22 On August 28, Xuhui Holding Group stated that the loss attributable to sharehold 08-28 22:04

Comments

0/500
验证码
No comments yet